Back
Milestone Pharmaceuticals Vs. Neurogene Industry Stock Comparison
Sell
49
MIST
Milestone Pharmaceuticals
Last Price:
1.89
Seasonality Move:
-18.41%
Sell
18
NGNE
Neurogene
Last Price:
22.87
Seasonality Move:
25.92%
Sell
49
Milestone Pharmaceuticals (MIST)
is a Sell
Is Milestone Pharmaceuticals a Buy, Sell or Hold?
- The current Milestone Pharmaceuticals [MIST] share price is $1.90. The Score for MIST is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $23.70. The Score for NGNE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MIST Stock Price Chart
What is Milestone Pharmaceuticals's stock price today?
-
The Milestone Pharmaceuticals share price today is $1.90
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIST is experiencing buying pressure, which is a positive indicator for future bullish movement.
NGNE Stock Price Chart
MIST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 59.87 | Buy |
| Chaikin Money Flow: | 139674 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.76 - 1.94) | Buy |
| Bollinger Bands (100): | (1.38 - 1.74) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.72 | Sell |
| Relative Strength Index (14 RSI): | 39.02 | Sell |
| Chaikin Money Flow: | -143683 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.46 - 51.84) | Sell |
| Bollinger Bands (100): | (28.57 - 50.73) | Sell |
MIST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.9 | Sell |
| 20-day SMA: | 1.85 | Buy |
| 50-day SMA: | 1.66 | Buy |
| 200-day SMA: | 1.58 | Buy |
| 8-day EMA: | 1.88 | Buy |
| 20-day EMA: | 1.83 | Buy |
| 50-day EMA: | 1.71 | Buy |
| 200-day EMA: | 1.75 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.39 | Buy |
| 20-day SMA: | 25.18 | Sell |
| 50-day SMA: | 40.98 | Sell |
| 200-day SMA: | 38.32 | Sell |
| 8-day EMA: | 23.6 | Buy |
| 20-day EMA: | 28.2 | Sell |
| 50-day EMA: | 35.54 | Sell |
| 200-day EMA: | 36.01 | Sell |
Milestone Pharmaceuticals Earnings Growth & MIST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.20 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
Milestone Pharmaceuticals Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||